Nifedipine, A Promising Drug for Prevention of Heart Changes During Weightlessness

Abstract

NASA plans to have a space station operating in 1994 and is considering a 30 month Mars flight. These plans call for exposure to microgravity for longer periods of time than space travelers have endured to date. Vascular deconditioning is known to occur during space flight and during simulated weightlessness. The degree of deconditioning for these extended flights and the amount of possible reversibility is unknown. If a sudden demanding burden should be placed on the astronaut after prolonged deconditioning, there could be serious consequences. Exercise has been tried with limited success. What is needed is a counter measure to deconditioning. Calcium channel blockers are known to protect the heart during the recovery phase after heart attacks by regulating the calcium influx, thus protecting the cell and mitochondria from calcium overload. Sudden demands also increase blood flow, mimicking the post attack reperfusion, and could be serious for a deconditioned heart. We have found nifedipine, a calcium channel blocker, to be a promising drug for prevention of structural changes during simulated weightlessness.